Can reverse payments in patent settlements constitute criminal cartel conduct?
It is a well-established and universally accepted principle of competition law that a payment by one competitor to another competitor not to enter a market is anticompetitive, and in Australia since 2010 a criminal offence. In the US over the past decade, drug companies, the Federal Trade Commission (FTC) and class action applicants have battled […]